English
Español

(805) 483 1185

Participate in a study!

Linkedin-in Instagram Facebook-f
01 Fomat_Logo_Website-min
proud-partner-HCI-V6
  • Home
  • About Us
  • For Sponsors & CROs
    • Services For Sponsors & CROs
    • Our Capabilities
      • eClinical Trials
      • NASH Capabilities
      • COVID Solutions
      • Vaccine Capabilities
  • For Patients
  • News & Updates
  • Contact FOMAT
  • │Fomat LatAm
  • US Careers

Home » Blogs & Updates » Page 2

Posts in category: Blogs & Updates

Diversity in Clinical Trials

The Importance of Diversity in Clinical Trials

November 22, 2021
by Beatriz Morales Blogs & Updates

Clinical trials are research studies performed on humans to help evaluate a new medical treatment, drug, or device. However, just like a disease, there is always a possibility that each of these medical products may have different outcomes for spec ...

Read More
Ventura County

Discover more about our educational programs for the Ventura County community

August 18, 2021
by Andrea Villasagua Blogs & UpdatesSocial Media

  Our mission as an Integrated Research Organization (IRO) is to diversify clinical trials by innovating healthcare for underrepresented populations while supporting the well-being of local communities. For this reason, we have developed an e ...

Read More
0
Volunteer

Why Volunteer in Clinical Trials?

August 10, 2021
by Beatriz Morales Blogs & UpdatesSocial Media

Why volunteer in clinical trials? Here's a summary of the reasons why clinical trials are important Clinical trials are research studies that use human participants to help evaluate new medical treatments, drugs, or devices. They are an essential to ...

Read More
0
aids

Ending AIDS: World Will Fall Short of 2020 Targets

August 11, 2020
by marketing_fomat Blogs & Updates

The 2020 targets set by UNAIDS to control global HIV/AIDS infection will not be met with "COVID-19 risks blowing HIV progress way off course," officials reported. According to the 2020 Global AIDS Update, 1.7 million people worldwide were newly infec ...

Read More
2
Novavax

Novavax Secures $1.6 Billion from U.S. Government for COVID-19 Vaccine Program

July 7, 2020
by marketing_fomat Blogs & Updates

With rising numbers of COVID-19 infections and as the fight against the novel coronavirus continues, Novavax received $1.6 billion in federal funding to support the clinical development of the company’s vaccine candidate, NVX‑CoV2373. Gaithersburg, ...

Read More
0
pharma lab-covid 19

Want to reopen your pharma lab amid COVID-19? Consider these strategies first

July 7, 2020
by marketing_fomat Blogs & Updates

COVID-19 has unleashed a logistical conundrum for pharma lab leaders: How do you keep momentum in therapeutics development, when, like all workplaces, most labs have had to either restrict use or close altogether? The answer lies, at least in part, i ...

Read More
1
covid-19-vaccine

Milken Institute Teams with First Person to Explain the Race to a COVID-19 Vaccine

June 15, 2020
by marketing_fomat Blogs & Updates

WASHINGTON--(BUSINESS WIRE)-- The Milken Institute, the nonprofit, nonpartisan think tank, and First Person, a San Francisco design and storytelling company, together tell the urgent story of the global race for a COVID-19 vaccine in a newly released ...

Read More
0
Covid-19 Virus Cell Images Photo

2 Million COVID-19 Cases | ‘Uniquely Worse Than I Can Remember’

June 15, 2020
by marketing_fomat Blogs & Updates

With the U.S. surpassing 2 million cases of COVID-19, infectious disease experts have learned a tremendous amount about SARS-CoV-2's transmissibility, the effects of infection, and how (or how not) to treat it. David Aronoff, MD, of Vanderbilt Uni ...

Read More
0
FDA

FDA Action Alert: Viela, Merck, Epizyme, Evoke and Regeneron

June 9, 2020
by marketing_fomat Blogs & Updates

The next two weeks are busy ones for the U.S. Food and Drug Administration (FDA). Here’s a look at PDUFA dates for this period. Viela Bio’s Inebilizumab for NMOSD Gaithersburg, Maryland-based Viela Bio has a target action date of June 11 for its Bi ...

Read More
0
covid

Biopharma Update on the Novel Coronavirus: June 8

June 9, 2020
by marketing_fomat Blogs & UpdatesCoronavirusNews

FDA Actions Reissued EUAs: The FDA reissued EUAs revising which types of respirators can be decontaminated for reuse. Availability and Capability of Non-Invasive Monitoring Devices: The FDA issued new guidance that expands the availability and capa ...

Read More
0
  • First
  • Previous
  • 1
  • 2
  • 3
  • 4
  • ...
  • 43
  • Next
  • Last

Recent Posts

  • FOMAT Continues to Encourage Diversity in Clinical Trials throughout California
  • FOMAT Medical Research Launches Phase 1 Services, Elevating Site Operations
  • Simon Corman Joins FOMAT to Help Innovate Healthcare Through Diversity
  • Innovating Our Services Alongside Our Ambulance of Research!
  • We are hiring a Project Manager! 

Categories

  • Aids
  • Allergies | Allergens
  • Alzheimer
  • Blogs & Updates
  • Breast Cancer
  • Cancer
  • Clinical Trials
  • Colds and Flu
  • Company Updates
  • Coronavirus
  • CRO Contract Research Organization
  • Crohn's Disease
  • Diabetes
  • Diseases
  • Disorders
  • Drug Discovery and Research
  • Ebola
  • eClinical Trials
  • Fertility Drugs
  • General
  • Lung Cancer
  • Marijuana
  • Medical Devices
  • Memory Loss
  • News
  • Research Studies
  • Social Media
  • Vaccines
  • Whitepapers

Upcoming Events

World Clinical Trials Congress

 March 20- 22, 2023

San Diego, CA

SCRS Diversity Site Solutions Summit

 March 30-31, 2023

Austin, TX

Contact Us

FOMAT Medical Research INC,
300 South A Street Suite 201 Oxnard, CA 93030
(805) 483 1185
Trial Information: [email protected]
General Information: [email protected]
  • Review us on Google
  • Review us on Yelp

Site Map | Privacy Policy

Shopping Basket